(Q37126345)

18 August 2017

1 reference

title

The molecular journey from ductal carcinoma in situ to invasive breast cancer (English)

1 reference

18 August 2017

1 reference

1 reference

Lisa Wiechmann

1

1 reference

18 August 2017

Henry M Kuerer

series ordinal

2

1 reference

18 August 2017

language of work or name

English

0 references

publication date

1 May 2008

1 reference

18 August 2017

1 reference

18 August 2017

volume

112

1 reference

18 August 2017

issue

10

1 reference

18 August 2017

page(s)

2130-2142

1 reference

Breast cancer risk associated with proliferative breast disease and atypical hyperplasia

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

Patterns of chromosomal alterations in breast ductal carcinoma in situ

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

Genetic relation of lobular carcinoma in situ, ductal carcinoma in situ, and associated invasive carcinoma of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

Ductal epithelial proliferations of the breast: a biological continuum? Comparative genomic hybridization and high-molecular-weight cytokeratin expression patterns.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsy: results from the Nurses' Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

Trends in the treatment of ductal carcinoma in situ of the breast.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

The finding of invasive cancer after a preoperative diagnosis of ductal carcinoma-in-situ: causes of ductal carcinoma-in-situ underestimates with stereotactic 14-gauge needle biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

The prognostic significance of multiple morphologic features and biologic markers in ductal carcinoma in situ of the breast: a study of a large cohort of patients treated with surgery alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

Detection of ductal carcinoma in situ in women undergoing screening mammography

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

21 January 2018

Cancer statistics, 2003.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

Gene expression profiles of human breast cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

The diagnosis and management of pre-invasive breast disease: promise of new technologies in understanding pre-invasive breast lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

Classification of ductal carcinoma in situ by gene expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

Molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

Repeated observation of breast tumor subtypes in independent gene expression data sets

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

Breast cancer classification and prognosis based on gene expression profiles from a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

Noninvasive ductal carcinoma of the breast: the relevance of histologic categorization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Intraductal carcinoma (ductal carcinoma in situ). The National Surgical Adjuvant Breast and Bowel Project Collaborating Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

Recent trends and racial/ethnic differences in the incidence and treatment of ductal carcinoma in situ of the breast in California women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

Reproducibility and validity of pathologic classifications of benign breast disease and implications for clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

Premalignant and in situ breast disease: biology and clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

Biology and treatment of ductal carcinoma in situ

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

Loss of heterozygosity in ductal carcinoma in situ of the breast.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

Prognostic and predictive molecular markers in DCIS: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

A prospective study of benign breast disease and the risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

Identification of a basal-like subtype of breast ductal carcinoma in situ

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

Loss of bcl-2 expression in ductal carcinoma in situ of the breast relates to poor histological differentiation and to expression of p53 and c-erbB-2 proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

COX-2 expression is associated with an aggressive phenotype in ductal carcinoma in situ

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

Biology of ductal carcinoma in situ classification based on biologic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

Clinicopathological study of the expression of hsp27, pS2, cathepsin D and metallothionein in primary invasive breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

Balance of cell proliferation and apoptosis in breast carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

Histological and biological evolution of human premalignant breast disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

Tumour markers in breast carcinoma correlate with grade rather than with invasiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

Biological markers that predict clinical recurrence in ductal carcinoma in situ of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

Biological features of premalignant disease in the human breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

Prognostic value of proliferation in invasive breast cancer: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

Ipsilateral local recurrence in relation to therapy and morphological characteristics in patients with ductal carcinoma in situ of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

Biological variables and prognosis of DCIS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

Immunohistochemical study of cell cycle regulatory proteins in intraductal breast carcinomas--a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

Down-regulation of T1A12/mac25, a novel insulin-like growth factor binding protein related gene, is associated with disease progression in breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

Downregulation of the potential suppressor gene IGFBP-rP1 in human breast cancer is associated with inactivation of the retinoblastoma protein, cyclin E overexpression and increased proliferation in estrogen receptor negative tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

Absence of HER4 expression predicts recurrence of ductal carcinoma in situ of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

S100A9 expression in invasive ductal carcinoma of the breast: S100A9 expression in adenocarcinoma is closely associated with poor tumour differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

Psoriasin (S100A7) expression and invasive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

Endometase/matrilysin-2 in human breast ductal carcinoma in situ and its inhibition by tissue inhibitors of metalloproteinases-2 and -4: a putative role in the initiation of breast cancer invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

Angiogenesis, thrombospondin, and ductal carcinoma in situ of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

Tumor specific VEGF-A and VEGFR2/KDR protein are co-expressed in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

Vascular density and phenotype around ductal carcinoma in situ (DCIS) of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

Thrombospondin 1 protein expression relates to good prognostic indices in ductal carcinoma in situ of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

COX-2 inhibitors. A new class of antiangiogenic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

Survivin expression in in situ and invasive breast cancer relates to COX-2 expression and DCIS recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

Progression-specific genes identified by expression profiling of matched ductal carcinomas in situ and invasive breast tumors, combining laser capture microdissection and oligonucleotide microarray analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

Gene expression signatures and biomarkers of noninvasive and invasive breast cancer cells: comprehensive profiles by representational difference analysis, microarrays and proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

Down regulation of bcl2 expression in invasive ductal carcinomas is both estrogen- and progesterone-receptor dependent and associated with poor prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

Distribution of Hsp-27 and HER-2/neu in in situ and invasive ductal breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

A prospective study of the development of breast cancer in 16,692 women with benign breast disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

7 January 2021

Genetic alterations in 'normal' luminal and myoepithelial cells of the breast

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

7 January 2021

Ductal invasive G2 and G3 carcinomas of the breast are the end stages of at least two different lines of genetic evolution

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

7 January 2021

Fifteen-year results of breast-conserving surgery and definitive irradiation for Stage I and II breast carcinoma: the University of Pennsylvania experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

7 January 2021

Re: Trends in the treatment of ductal carcinoma in situ of the breast

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

7 January 2021

Variations in diagnostic and therapeutic procedures in a multicentre, randomized clinical trial (EORTC 10853) investigating breast-conserving treatment for DCIS

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

7 January 2021

Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853. EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

7 January 2021

Consensus conference on the classification of ductal carcinoma in situ

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

7 January 2021

The Consensus Conference on the Treatment of in situ Ductal Carcinoma of the Breast, 22-25 April 1999

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

7 January 2021

Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: A guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

7 January 2021

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

7 January 2021

Microsatellite alterations indicating monoclonality in atypical hyperplasias associated with breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

7 January 2021

Assessment of lesions coexisting with various grades of ductal intraepithelial neoplasia of the breast

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

7 January 2021

Risk factors for breast cancer in women with proliferative breast disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

7 January 2021

Ki-67 immunostaining in 322 primary breast cancers: associations with clinical and pathological variables and prognosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

7 January 2021

Potential value of hormone receptor assay in carcinoma in situ of breast

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

7 January 2021

Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

7 January 2021

E-cadherin (E-cad) expression in duct carcinoma in situ (DCIS) of the breast

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

7 January 2021

Ductal carcinoma in situ of the breast and heparanase-1 expression: a molecular explanation for more aggressive subtypes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

7 January 2021

Microvessel density and distribution in ductal carcinoma in situ of the breast

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

7 January 2021

Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in cervical neoplasia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

7 January 2021

Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in patients with ductal carcinoma in situ of the breast

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

7 January 2021

Angiogenesis and invasive recurrence in ductal carcinoma in situ of the breast

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23430

7 January 2021

Identifiers

DOI

10.1002/CNCR.23430

1 reference

18 August 2017

1 reference